Approval · Notice of Compliance 926 · 2003
KYTRIL: Notice of Compliance 926
Issued December 5, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 926
- Date
- December 5, 2003
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indications: prevention and treatment of post-operative nausea and vomiting
- Therapeutic class
- Antiemetic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KYTRIL | Not yet assigned | — |
Medicinal ingredients
- GRANISETRON HCL 1 MG per ML